AtriCure, Inc. ATRC revenue by segment, product and geography
In its fiscal year ending 2025-12-31, AtriCure, Inc. reported revenue across 1 products and services; the largest, Shipping And Handling, was $2.45M, 100.0% of the filed sum (+1.2% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Shipping And Handling$2.45M100.0%+1.2% yoy
Members sum to $2.45M against $535M consolidated (residual $532M) - eliminations or corporate lines the filer did not tag on this axis.
- United States$435Mshare n/a+13.7% yoy
- Outside the United States$99.2Mshare n/a+20.2% yoy
- Europe$61.5Mshare n/a+23.3% yoy
- Asia Pacific$30.7Mshare n/a+12.2% yoy
- Other International$6.94Mshare n/a+32.5% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- United States$126Mshare n/a+13.6% yoy
- Outside the United States$28Mshare n/a+9.6% yoy
- Europe$17.2Mshare n/a+6.7% yoy
- Asia Pacific$8.63Mshare n/a+15.4% yoy
- Other International$2.17Mshare n/a+12.1% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.